Chivosazoles A and F, cytostatic macrolides from myxobacteria, interfere with actin

ChemBioChem

Volumn 10, Issue 18, 2009, Pages 2900-2903

  Diestel, Randi ^a   Irschik, Herbert ^a   Jansen, Rolf ^a   Khalil, Mohammed W ^a,b   Reichenbach, Hans ^a   Sasse, Florenz ^a  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^b FAYOUM UNIVERSITY   (Egypt)

Author keywords

Actin; Biological activity; Cell cycle; Chivosazole; Cytochalasin; Rhizopodin

Indexed keywords

ANTINEOPLASTIC AGENT; CHIVOSAZOLES A; CHIVOSAZOLES F; CYTOCHALASIN D; F ACTIN; G ACTIN; UNCLASSIFIED DRUG;

ACTIN POLYMERIZATION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSKELETON; DEPOLYMERIZATION; DRUG BIOAVAILABILITY; DRUG STRUCTURE; HUMAN; HUMAN CELL; IC 50; MITOSIS; MYXOCOCCALES; PRIORITY JOURNAL;

ACTINS; ANIMALS; CELL DIVISION; CELL LINE, TUMOR; G2 PHASE; HUMANS; MACROLIDES; MICE; MICROFILAMENTS; MULTIGENE FAMILY; MYXOCOCCALES;

MAMMALIA; MYXOCOCCALES; POLYANGIUM CELLULOSUM;

EID: 72949094890     PISSN: 14394227     EISSN: 14397633     Source Type: Journal    
DOI: 10.1002/cbic.200900562     Document Type: Article

References (19)

1. F. C. S. Ramaekers, F. T. Bosman, J. Pathol. 2004, 204, 351- 354.
2. a) M. W. Khalil, F. Sasse, H. Lünsdorf, Y. A. Elnakady, H. Reichenbach, ChemBioChem 2006, 7, 678- 683;
3. b) Y. A. Elnakady, F. Sasse, H. Lünsdorf, H. Reichenbach, Biochem. Pharmacol. 2004, 67, 927 -935;
4. c) D. M. Bollag, P. A. McQueney, J. Zhu, O. Hensens, L. Koupal, J. Liesch, M. Goetz, E. Lazarides, C. M. Woods, Cancer Res. 1995, 55, 2325- 2333.
5. a) T. M. A. Gronewold, F. Sasse, H. Lünsdorf, H. Reichenbach, Cell Tissue Res. 1999, 295, 121 -129;
6. b) F. Sasse, B. Kunze, T. M. Gronewold, H. Reichenbach, J. Natl. Cancer Inst. 1998, 90, 1559 - 1563;
7. c) U. Eggert, R. Diestel, F. Sasse, R. Jansen, B. Kunze, M. Kalesse, Angew. Chem. 2008, 120, 6578 - 6582;
8. Angew. Chem. Int. Ed. 2008, 47, 6478 -6482.
9. a) H. Irschik, R. Jansen, K. Gerth, G. Höfle, H. Reichenbach, J. Antibiot. 1995, 48, 962- 966;
10. b) R. Jansen, H. Irschik, H. Reichenbach, G. Höfle, Liebigs Ann. 1997, 1725 -1732.
11. D. Janssen, D. Albert, R. Jansen, R. Müller, M. Kalesse, Angew. Chem. 2007, 119, 4985 - 4988;
12. Angew. Chem. Int. Ed. 2007, 46, 4898 - 4901.
13. O. Perlova, K. Gerth, O. Kaiser, A. Hans, R. Müller, J. Biotechnol. 2006, 121, 174-191.
14. G. Hagelueken, S. C. Albecht, H. Steinmetz, R. Jansen, D. W. Heinz, M. Kalesse, W.-D. Schubert, Angew. Chem. 2009, 121, 603- 606;
15. Angew. Chem. Int. Ed. 2009, 48, 595-598.
16. a) D. W. Goddette, C. Frieden, J. Biol. Chem. 1986, 261, 15974 -15980;
17. b) U. B. Nair, P. B. Joel, Q. Wan, S. Lowey, M. A. Rould, K. M. Trybus, J. Mol. Biol. 2008, 384, 848- 864.
18. a) J. S. Allingham, V. A. Klenchin, I. Rayment, Cell. Mol. Life Sci. 2006, 63; 2119-2134;
19. b) R. D. Perrins, G. Cecere, I. Paterson, G. Mariott, Chem. Biol. 2008, 15, 287 -294.